Cargando…
The regulatory challenges of innovative customized combination products
BACKGROUND/AIMS: Combination products are therapeutic and/or diagnostic products that can combine drugs and medical devices and which increasing complexity has raised new regulatory framework challenges. To reach the market, a combination product must be classified based on the principal mode of act...
Autores principales: | Reis, Mariana E., Bettencourt, Ana, Ribeiro, Helena M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354569/ https://www.ncbi.nlm.nih.gov/pubmed/35935795 http://dx.doi.org/10.3389/fmed.2022.821094 |
Ejemplares similares
-
Digital Innovation in Medicinal Product Regulatory Submission, Review, and Approvals to Create a Dynamic Regulatory Ecosystem—Are We Ready for a Revolution?
por: Macdonald, Judith C., et al.
Publicado: (2021) -
Importance Calculation of Customer Requirements for Incremental Product Innovation
por: Geng, Lisha, et al.
Publicado: (2021) -
Editorial: Innovation in Rheumatic Diseases
por: Jacinto, Maria João, et al.
Publicado: (2022) -
Regulatory policy and pharmaceutical innovation in the United Kingdom after Brexit: Initial insights
por: Hofer, Matthias P., et al.
Publicado: (2022) -
Benefits of mass customized products: moderating role of product involvement and fashion innovativeness
por: Park, Minjung, et al.
Publicado: (2018)